Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

C-Cure Drug Analysis 2018: A Bone Marrow-Derived Stem Cell Therapy Aimed at Regenerating Cardiac Tissue Following Severe Damage Due to Myocardial Infarctions - ResearchAndMarkets.com

Research and Markets
Posted on: 16 Feb 18

The "Drug analysis: C-Cure" drug pipelines has been added to ResearchAndMarkets.com's offering.

C-Cure is a bone marrow-derived stem cell therapy aimed at regenerating cardiac tissue following severe damage due to myocardial infarctions. C-Cure consists of a patient's own cells harvested from bone marrow, which are treated with Celyad's proprietary cell culture to form autologous heart muscle cells. These cells are then re-injected directly into the scar tissue of the patient's heart to repopulate the damaged areas and improve cardiac function.

Key Topics Covered:

List of Figures
Figure 1: C-Cure for chronic heart failure - SWOT analysis
Figure 2: Drug assessment summary of C-Cure for chronic heart failure
Figure 3: Drug assessment summary of C-Cure for chronic heart failure
Figure 4: C-Cure sales for chronic heart failure across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables
Table 1: C-Cure drug profile
Table 2: C-Cure's proposed Phase III trial design in chronic heart failure
Table 3: C-Cure completed late-phase data in chronic heart failure
Table 4: C-Cure sales for chronic heart failure across the US, Japan, and five major EU markets, by country ($m), 2017-26

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/p8rkdn/ccure_drug?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180216005306/en/

Business Wire
www.businesswire.com

Last updated on: 16/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.